Eagle Pharmaceuticals Inc (EGRX)
0.7138
+0.01
(+1.91%)
USD |
OTCM |
Nov 15, 12:37
Eagle Pharmaceuticals Cash and Short Term Investments (Quarterly): 15.35M for June 30, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 15.35M |
| March 31, 2023 | 21.90M |
| December 31, 2022 | 55.32M |
| September 30, 2022 | 15.38M |
| June 30, 2022 | 36.56M |
| March 31, 2022 | 69.52M |
| December 31, 2021 | 97.66M |
| September 30, 2021 | 99.74M |
| June 30, 2021 | 108.72M |
| March 31, 2021 | 105.23M |
| December 31, 2020 | 103.16M |
| September 30, 2020 | 89.68M |
| June 30, 2020 | 108.21M |
| March 31, 2020 | 202.02M |
| December 31, 2019 | 109.78M |
| September 30, 2019 | 117.21M |
| June 30, 2019 | 108.13M |
| March 31, 2019 | 102.14M |
| December 31, 2018 | 78.79M |
| September 30, 2018 | 91.23M |
| Date | Value |
|---|---|
| June 30, 2018 | 100.25M |
| March 31, 2018 | 95.67M |
| December 31, 2017 | 114.66M |
| September 30, 2017 | 97.54M |
| June 30, 2017 | 55.38M |
| March 31, 2017 | 27.71M |
| December 31, 2016 | 52.82M |
| September 30, 2016 | 59.31M |
| June 30, 2016 | 75.56M |
| March 31, 2016 | 78.29M |
| December 31, 2015 | 79.08M |
| September 30, 2015 | 95.98M |
| June 30, 2015 | 103.68M |
| March 31, 2015 | 115.92M |
| December 31, 2014 | 34.87M |
| September 30, 2014 | 42.72M |
| June 30, 2014 | 49.79M |
| March 31, 2014 | 54.88M |
| December 31, 2013 | 9.974M |
| September 30, 2013 | 10.46M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
15.35M
Minimum
Jun 2023
202.02M
Maximum
Mar 2020
82.55M
Average
97.66M
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Eli Lilly and Co | 3.518B |
| Verrica Pharmaceuticals Inc | 22.96M |
| NovaBay Pharmaceuticals Inc | 0.776M |
| Palatin Technologies Inc | 9.527M |
| iBio Inc | 14.21M |